Actively Recruiting
Impact of Ambulatory Continuous Monitoring Using Remote Monitoring Medicine Within Patient's Care Pathway Following Colorectal Surgery (CONTACT-GRECCAR 21)
Led by Nantes University Hospital · Updated on 2026-03-19
362
Participants Needed
14
Research Sites
99 weeks
Total Duration
On this page
Sponsors
N
Nantes University Hospital
Lead Sponsor
E
EPOCA U&I
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this Clinical Investigation is to evaluate the effectiveness of implementing the discharge protocol of the remote monitoring platform after colorectal surgery in patients at risk of hospital readmission. Participants will be randomized into either the "30 days of remote monitoring" group or the "conventional discharge" group. The patient returns to the site for their postoperative visit at 30 days and is contacted by phone 90 days after their surgery.
CONDITIONS
Official Title
Impact of Ambulatory Continuous Monitoring Using Remote Monitoring Medicine Within Patient's Care Pathway Following Colorectal Surgery (CONTACT-GRECCAR 21)
Who Can Participate
Eligibility Criteria
You may qualify if you...
Inclusion Criteria :
- Man or woman over 18 years old at the time of the J0 visit,
- Patient who underwent surgery less than 28 days ago, or who is scheduled to undergo colorectal surgery not managed as an outpatient procedure at the investigational center, including resection of at least one colonic or rectal segment and/or an anastomosis involving the colon or rectum,
- At least one of the following two criteria:
- Anticipated early discharge (within 24 hours following laparoscopic surgery without stoma and without diversion, and within 5 days following laparotomy and/or surgery with stoma and/or rectal surgery) for a procedure that is not usually managed as an outpatient surgery in routine practice,
- Estimated risk of hospital readmission greater than 10% according to the nomogram of Tevis et al. [15], adapted to the postoperative context in digestive surgery (>120 points according to this score).
- Patient affiliated with a health insurance plan,
- Patient who has signed the study consent form.
Exclusion Criteria:
- Discharge to a rehabilitation center requested by the patient,
- Condition managed on an outpatient basis in routine practice for this type of patient,
- Patient eligible for home hospitalization services,
- Suicidal or hetero-aggressive risk in a patient living alone at home
- Homeless patient,
- Pregnant or breastfeeding women,
- Patient under legal guardianship, curatorship, or protected legal status,
- Patient already enrolled in an interventional postoperative follow-up study.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 14 locations
1
CHU Angers
Angers, France
Actively Recruiting
2
Clinique Tivoli- Ducos
Bordeaux, France
Actively Recruiting
3
CHU Grenoble
Grenoble, France
Actively Recruiting
4
Centre Hospitalier Lyon-Sud
Lyon, France
Actively Recruiting
5
CHU Timone - Assistance publique-Hôpitaux de Marseille
Marseille, France
Actively Recruiting
6
Hôpital Nord - Assistance publique- Hôpitaux de Marseille
Marseille, France
Actively Recruiting
7
Institut Paoli Calmettes
Marseille, France
Not Yet Recruiting
8
CHU Nantes
Nantes, France
Actively Recruiting
9
Hôpital de Bicêtre - Assistance Publique Hôpitaux de Paris
Paris, France
Actively Recruiting
10
Hôpital Saint Antoine - Assistance publique - Hôpitaux de Paris
Paris, France
Actively Recruiting
11
CHU Rennes
Rennes, France
Actively Recruiting
12
Clinique Mutualiste de l'estuaire
Saint-Nazaire, France
Actively Recruiting
13
CHU Toulouse
Toulouse, France
Actively Recruiting
14
CHRU Tours
Tours, France
Actively Recruiting
Research Team
E
Emilie DUCHALAIS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here